Stymied, Moving Forward or Both? The Long-COVID (and ME/CFS) Clinical Trials Dilemma
Big pharma is largely staying clear of long COVID trials but the many small and some quite large clinical trials are underway provide hope.
Long COVID Invasive Exercise Study Suggests Purine Inhibitors May Help
A long COVID invasive exercise metabolomic study found reduced energy production and recommended purine inhibiting drugs.
Plasmapheresis Possibilities for ME/CFS and Long COVID Pt. 2: Immunoadsorption, BC007 and H.E.L.P.
Check out how blood cleansing techniques to remove pathogenic factors in chronic fatigue syndrome (ME/CFS) and long COVID may (or may not) be helping in these diseases.
Nalmefene: Has Jarred Younger Discovered a Better LDN + an LDN / Rapamycin Osteoporesis Connection
Nalmefene may work better than low-dose naltrexone in ME/CFS, fibromyalgia, and long COVID, plus LDN and Rapamycin may help with osteoporosis.
Simmaron’s Rapamycin ME/CFS Trial Moves Forward: The Goal – FDA Approval
A successful rapamycin clinical trial in chronic fatigue syndrome (ME/CFS) leads to more studies and perhaps FDA approvalStudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
